Patrick D Yeramian is Chief Medical Officer of Amylyx Pharmaceuticals, Inc.. Currently has a direct ownership of 205,605 shares of AMLX, which is worth approximately $795,691. The most recent transaction as insider was on Jan 09, 2024, when has been sold 2,812 shares (Common Stock) at a price of $16.33 per share, resulting in proceeds of $45,919. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 206K
0% 3M change
1.35% 12M change
Total Value Held $795,691

Patrick D Yeramian Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 09 2024
SELL
Open market or private sale
$45,919 $16.33 p/Share
2,812 Reduced 1.35%
205,605 Common Stock
May 15 2023
SELL
Open market or private sale
$347,343 $29.03 p/Share
11,965 Reduced 5.43%
208,417 Common Stock
May 15 2023
BUY
Exercise of conversion of derivative security
$43,432 $3.63 p/Share
11,965 Added 5.15%
220,382 Common Stock
Apr 17 2023
SELL
Open market or private sale
$1,524,058 $30.74 p/Share
49,579 Reduced 19.22%
208,417 Common Stock
Apr 17 2023
BUY
Exercise of conversion of derivative security
$179,971 $3.63 p/Share
49,579 Added 16.12%
257,996 Common Stock
Mar 16 2023
SELL
Open market or private sale
$1,755,711 $32.14 p/Share
54,627 Reduced 26.74%
149,672 Common Stock
Mar 16 2023
BUY
Grant, award, or other acquisition
-
9,167 Added 5.46%
158,839 Common Stock
Jan 06 2023
BUY
Open market or private sale
$74,118 $36.44 p/Share
2,034 Added 0.99%
204,299 Common Stock
Jan 06 2022
BUY
Grant, award, or other acquisition
-
28,333 Added 12.07%
206,333 Common Stock
PDY

Patrick D Yeramian

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on AMLX

Follow Amylyx Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMLX shares.

Notify only if

Insider Trading

Get notified when an Amylyx Pharmaceuticals, Inc. insider buys or sells AMLX shares.

Notify only if

News

Receive news related to Amylyx Pharmaceuticals, Inc.

Track Activities on AMLX